SCHEMBL18992012

SCHEMBL18992012

CC1(C)CNC[C@](Cc2ccccc2)(NC(=O)OC(C)(C)C)C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSS P25774 6/20 0.42
CTSL P07711 3/20 0.42
CTSB P07858 3/20 0.42
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA7 P43166 1/20 0.40
CA14 Q9ULX7 1/20 0.40
PPIA P62937 1/20 0.39
AKT1 P31749 2/20 0.39
CTSK P43235 2/20 0.38
ATM Q13315 1/20 0.37
KMT2A Q03164 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
NPFFR1 Q9GZQ6 1/20 0.37
NPFFR2 Q9Y5X5 1/20 0.37
DPP8 Q6V1X1 1/20 0.37
DPP9 Q86TI2 1/20 0.37
IDO1 P14902 1/20 0.37
GRIN2B Q13224 1/20 0.36
PPARA Q07869 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18991773 0.84 ALDH1A1 (0.38) KMT2A
SCHEMBL1035119 0.83 PPIA (0.42) CTSSCTSLCTSBCA12CA1
SCHEMBL5381278 0.81 PPIA (0.49) CTSSCTSLCTSBCA12CA1
SCHEMBL2476094 0.80 KMT2A (0.40) CTSSCTSLCTSBCA12CA1
SCHEMBL2480628 0.80 KMT2A (0.40) CTSSCTSLCTSBCA12CA1
SCHEMBL19559839 0.79 ADRB2 (0.52) CTSSCTSLCTSBCA12CA1
SCHEMBL6167707 0.78 CA12 (0.40) CTSSCTSLCTSBCA12CA1
SCHEMBL15261788 0.74 CA12 (0.46) CTSSCTSLCTSBCA12CA1
SCHEMBL458294 0.74 CA12 (0.39) CTSSCTSLCTSBCA12CA1
SCHEMBL12500571 0.72 DRD2 (0.39) CA12CA1CA7CA14AKT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3390389-A1 POLYCYCLIC TLR7/8 ANTAGONISTS AND USE THEREOF IN THE TREATMENT OF IMMUNE DISORDERS Merck Patent GmbH (DE) 2018-10-24 EP disclosed
WO-2017106607-A1 POLYCYCLIC TLR7/8 ANTAGONISTS AND USE THEREOF IN THE TREATMENT OF IMMUNE DISORDERS MERCK PATENT GMBH (DE) 2017-06-22 WO disclosed